| CCO
Registration and Breakfast/Coffee Talk with Key Opinion Leaders In-person learners are invited to start off the morning with key opinion leaders as well as other colleagues to enjoy coffee and …
Complexities in HER2+ MBC | CCO - clinicaloptions.com
May 7, 2025 · As a nationally recognized provider of continuing education for healthcare professionals, CCO develops, delivers, and evaluates a broad range of accredited, cutting …
Schizophrenia Treatment | CCO
Mar 27, 2025 · As a nationally recognized provider of continuing education for healthcare professionals, CCO develops, delivers, and evaluates a broad range of accredited, cutting …
MM FAQ | CCO - clinicaloptions.com
Mar 5, 2025 · As a nationally recognized provider of continuing education for healthcare professionals, CCO develops, delivers, and evaluates a broad range of accredited, cutting …
FLT3-Mutated AML | CCO
Apr 30, 2025 · As a nationally recognized provider of continuing education for healthcare professionals, CCO develops, delivers, and evaluates a broad range of accredited, cutting …
REPRIEVE Mexico | CCO
Aug 17, 2023 · As a nationally recognized provider of continuing education for healthcare professionals, CCO develops, delivers, and evaluates a broad range of accredited, cutting …
Lenacapavir Approval | CCO
Aug 14, 2025 · As a nationally recognized provider of continuing education for healthcare professionals, CCO develops, delivers, and evaluates a broad range of accredited, cutting …
GLP-1 RAs for CKD in T2D | CCO - clinicaloptions.com
Oct 31, 2024 · As a nationally recognized provider of continuing education for healthcare professionals, CCO develops, delivers, and evaluates a broad range of accredited, cutting …
Abemaciclib in EBC | CCO - clinicaloptions.com
Nov 29, 2021 · As a nationally recognized provider of continuing education for healthcare professionals, CCO develops, delivers, and evaluates a broad range of accredited, cutting …
Cancer Conversations: RCC - Multimedia - RCC Conversations | CCO
From Clinical Care Options (CCO), an expert video webinar on immunotherapy and targeted agents in RCC treatment